Lupin said it will market Eglucent through its own specialty field force while Lilly will be responsible for manufacturing and import.

According to the agreement, Lupin will market and sell Eglucent through its own specialty field force while Lilly will be responsible for m...

US-based pharmaceutical major Eli Lilly and Company expects to be among the top 20 drug makers in India by 2020

To take advantage of the robust growth of the domestic pharma industry, MNCs are looking at alliances and partnerships.

Wockhardt is planning to restart production of human recombinant insulin Wosulin (50:50), for which the State Food and Drug Administration ...